ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

LncRNA RP4-639F20.1 interacts with THRAP3 to attenuate atherosclerosis by regulating c-FOS in vascular smooth muscle cells proliferation and migration

Zhang, Ruyi; Bu, Fan; Wang, Yubing; Huang, Mei; Lin, Xiaomin; Wu, Changmeng; Chen, Juanjiang; Huang, Yiyi; Wang, Haifang; Ye, Shu; Hu, Xiumei*; Wang, Qian*; Zheng, Lei*南方医科大学; 汕头大学
Atherosclerosis2023-8DOI: 10.1016/j.atherosclerosis.2023.06.974
26阅读
引用收藏
分享

摘要

Background and aims: The aberrant proliferation and migration of vascular smooth muscle cells (VSMCs) play an essential role in the pathogenesis of atherosclerosis (AS). Long noncoding RNAs (lncRNAs) have been reported as important regulators in a number of diseases. However, very little is known regarding the functional role of lncRNAs in governing proliferation and migration of VSMCs and AS development.Methods: Both in vitro and in vivo assays were performed to investigate the role of lncRNA in the pathophysiology of AS. Our previous lncRNA arrays revealed that lncRNA RP4-639F20.1 was significantly decreased in atherosclerotic plaques. Lentivirus overexpressing RP4-639F20.1 and lncRNA RP4-639F20.1 silencing vectors (Si-lncRP4-639F20.1) were constructed and transfected in VSMCs. The in vitro functions of lncRNA were analyzed by CCK-8 assays, EdU assays, scratch wound assays, transwell assays, qRT-PCR and Western blot analyses. RNA fluorescence in situ hybridization, immunoprecipitation and mRNA microarrays were used to explore the underlying mechanism. Adeno-associated-virus-9 (AAV9) overexpressing RP4-639F20.1 was constructed and injected intravenously into ApoE-/- mice to explore the role of lncRNA in vivo. Results: In vitro experiments showed that lncRNA RP4-639F20.1 interacted with THRAP3 and downregulated cFOS expression. Both increase of lncRNA RP4-639F20.1 expression and knockdown of c-FOS inhibited the expression of MMP10 and VEGF-& alpha; in VSMCs and suppressed VSMCs proliferation and migration. In vivo experiments using ApoE-/- mice fed a high-fat diet demonstrated that lncRNA RP4-639F20.1 overexpression deterred atherosclerosis and decreased lipid levels in atherosclerotic lesions. Patients with coronary artery disease were found to have higher c-FOS levels than healthy individuals and c-FOS expression was positively correlated with the SYNTAX score of patients.Conclusions: Overall, these data indicated that lncRNA RP4-639F20.1/THRAP3/c-FOS pathway protects against the development of atherosclerosis by suppressing VSMCs proliferation and migration. LncRNA RP4-639F20.1 and c-FOS could represent potential therapeutic targets to ameliorate atherosclerosis-related diseases.

学科与关键词

关键词
LncRNAAtherosclerosisProliferationMigrationVascular smooth muscle cell
相关
加载中…
  • lncRNA RP11-531A24.3 inhibits the migration and proliferation of vascular smooth muscle cells by downregulating ANXA2 expression
    Wu, Yilin; Cai, Fen; Lu, Yuanbin; Hu, Yanwei*; Wang, Qian*Experimental and Therapeutic Medicine, 2021, 22(6): 1439.被引 3
  • LncRNA AC105942.1 Downregulates hnRNPA2/B1 to Attenuate Vascular Smooth Muscle Cells Proliferation
    Zhang, Ru-Yi; Wu, Chang-Meng; Hu, Xiu-Mei; Lin, Xiao-Min; Hua, Yu-Neng; Chen, Jun-Jiang; Ding, Li; He, Xin; Yang, Biao; Ping, Bao-Hong; Zheng, Lei*; Wang, Qian*DNA and Cell Biology, 2021, 40(5): 652-661.被引 10
  • Long non-coding RNA AL355711 promotes smooth muscle cell migration through the ABCG1/MMP3 pathway
    Kang, Chun-Min; Li, Wei-Kang; Yu, Ke-Wei; Li, Xue-Heng; Huang, Rui-Ying; Ke, Pei-Feng; Jin, Xing; Cao, Shun-Wang; Yuan, Ying-Shi; Wang, Heng; Yan, Jun; Chen, Wei-Ye; Huang, Xian-Zhang*; Zhao, Jing-Jing*International Journal of Molecular Medicine, 2021, 48(6): 207.被引 4
查看全部 →

发表信息

论文状态
公开发表
期刊
Atherosclerosis
发表日期
2023-08
卷期
第 379 卷
页码
117183
DOI
10.1016/j.atherosclerosis.2023.06.974
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Sciences Foundation of China [82070466, 2021YFA1300604]; National Key Ramp;D Program of China [82025024]; National Science Fund for Distinguished Young Scholars [82230080]; Key project of the National Natural Science Foundation of China [20171A011251]; Medical and Health Science and Technology Project Fund of Guangzhou Municipal Health Bureau [2021B023]; President Foundation of Nanfang Hospital, Southern Medical University; [82072334]

作者

  • Z

    Zhang, Ruyi (第一作者)

    southern med univ

  • B

    Bu, Fan

    southern med univ

查看全部 13 位作者收起作者
  • W

    Wang, Yubing

    southern med univ

  • H

    Huang, Mei

    southern med univ

  • L

    Lin, Xiaomin

    southern med univ

  • W

    Wu, Changmeng

    southern med univ

  • C

    Chen, Juanjiang

    southern med univ

  • H

    Huang, Yiyi

    southern med univ

  • W

    Wang, Haifang

    southern med univ

  • Y

    Ye, Shu

    shantou univ

  • H

    Hu, Xiumei (通讯)

    southern med univ

  • W

    Wang, Qian (通讯)

    southern med univ

  • Z

    Zheng, Lei (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417